- Our Story
- Our Products
- Our Science
- Our People
- Our Citizenship
-
Investors
- Reports and Filings
- Presentations
-
Shares
- Share Price
- Stock Updates
- Equity & Dividend History
- Unpaid & Unclaimed Dividend
- Analyst Coverage
- Shareholding Pattern
- Share Transfer Information
- Buyback
- Details of Shares for transfer to IEPF August 17
- Notice pursuant to IEPF Rules, Aug 17
- Details of Shares for transfer to IEPF May 2018
- Notice pursuant to IEPF Rules, May 2018
- Governance
- Investor Services
- Media
- Partners
- Canada
- Australia
- Germany
- India
- New Zealand
- China
- Netherlands
- Contact Us
Press Releases
Feb
Jan
- Dr. Reddy's Laboratories and its U.S. subsidiary, Promius Pharma, announce FDA approval for TOSYMRA™ (sumatriptan nasal spray) 10 mg, in the U.S. market
- Dr. Reddy's Laboratories announces the launch of Propofol Injectable Emulsion, USP in the U.S. Market
- Dr. Reddy's Laboratories Limited to present at the 37th Annual J.P. Morgan Healthcare Conference
